NCT04363528 (COVIDOP-DVT) is a NA clinical trial of Doppler Echo in Deep Vein Thrombosis, sponsored by Versailles Hospital.

Who is sponsoring NCT04363528?

NCT04363528 is sponsored by Versailles Hospital.

What drugs are being tested in NCT04363528?

Interventions in NCT04363528: Doppler Echo.

What condition does NCT04363528 study?

NCT04363528 studies Deep Vein Thrombosis.

Is NCT04363528 still recruiting?

NCT04363528 is currently completed. Last updated 26 July 2022.

Last reviewed 2022-07-26 · How we verify

NCT04363528: COVIDOP-DVT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU

Completed NA Last updated 26 July 2022

What this trial tests

NA trial testing Doppler Echo in Deep Vein Thrombosis in 50 participants. Completed in 24 June 2021.

Timeline

24 April 2020

Primary endpoint
24 December 2020

24 June 2021

Quick facts

Lead sponsor	Versailles Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	50
Start date	24 April 2020
Primary completion	24 December 2020
Estimated completion	24 June 2021
Sites	1 location across France

Drugs / interventions tested

Doppler Echo

Conditions studied

Deep Vein Thrombosis — all drugs for Deep Vein Thrombosis →

Sponsor

Versailles Hospital

Who can join

18 and older, any sex, with Deep Vein Thrombosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the study is to determine the incidence of deep vein thromboses at Doppler echo in patients with SARS-Cov-2 pneumopathy upon their entry into ICU and after 7 days of hospitalization in ICU. This is a monocentric interventional study (RIPH 2).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management.
Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, et al · · 2020 · cited 465× · PMID 32788101 · DOI 10.1016/j.thromres.2020.06.029

Verify or expand the search:

Other recruiting trials for Deep Vein Thrombosis

Currently open trials in the same condition.

NCT06886516 — Apixaban in Thrombocytopenia · EARLY_PHASE1 · recruiting
NCT06842446 — Systematic Machine Learning Algorithm for Rapid Thrombosis Detection · NA · recruiting
NCT06581965 — inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Tota · Phase 4 · recruiting
NCT06989255 — A Multi-center Cohort Study for Conventional Ultrasound Image Set Collection to Create a Data Set for Research Purposes. · recruiting
NCT06727669 — Longitudinal Cohort of Thrombosis and Hemostasis Diseases · recruiting

Other Versailles Hospital trials

Trials by the same sponsor.

NCT07369245 — Techniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction · NA · not yet recruiting
NCT07383779 — Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status Epilepticus · Phase 3 · not yet recruiting
NCT06835491 — Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac · Phase 3 · recruiting
NCT07476755 — Cross-cultural Adaptation and Validation of the French Version of the Social Media Disorder Scale for Parents in a Sampl · completed
NCT06650813 — Adapting the FACETS Program to Sickle Cell Disease · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04363528 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Versailles Hospital
Last refreshed: 26 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04363528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing